ARCHIVES

Report Urges Changes To Cut Activation Times For NCI Phase III Trials.

This article is from The Cancer Letter archive.

Vol. 36 No. 13 | April 9, 2010

Download PDF Visit The Full Archive

Related Articles

Hawking Hearings Turn Up Difference Between Management, Staff At FDA

November 20, 1981

In Brief: Moorehead Heads ACCC; Anderson President Elect; Segaloff Dies; RAAD Cleveland Clinic Director

March 22, 1985

Goodfellow To Lead Gynecologic Oncology Research Team At Ohio State University

January 11, 2013

Professional Societies: ASCO opposes FDA On Stem Cell Transplant Regs

May 16, 1997

Program Announcements n Animal Retroviruses, Other Topics, Approved

March 30, 1990

Frelick Heads ACCC, Kerman Names President-Elect

March 14, 1980